Corpus Intelligence IC Memo — CARL ALBERT COMMUNITY MENTAL HEALTH 2026-04-26 17:22 UTC
IC Memo — CARL ALBERT COMMUNITY MENTAL HEALTH
Investment Committee Memorandum | OK | 16 beds | Grade D | EBITDA uplift $319K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CARL ALBERT COMMUNITY MENTAL HEALTH

CCN 374006 | PITTSBURGH, OK | 16 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CARL ALBERT COMMUNITY MENTAL HEALTH is a 16-bed safety-net/medicaid heavy in PITTSBURGH, OK with $4.2M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 12.1% Medicare, 55.5% Medicaid, and 32.4% commercial.

Thesis: Turnaround. Our ML models identify $319K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -365.6% (+767bps).

Net Revenue HCRIS$4.2M
Current EBITDA COMPUTED$-15.5M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS88.7%
Revenue / Bed COMPUTED$260K
Net-to-Gross HCRIS17.8%
Distress Probability ML51.1%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
57
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -100.0% places it below the state median. Among 57 size-comparable peers (8-32 beds), the median margin is -17.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CARL ALBERT COMMUNITY MENTAL H (Target)OK16$4.2M-100.0%
OKLAHOMA SPINE HOSPITALOK23$79.0M8.4%
BRISTOW MEDICAL CENTEROK25$48.5M-12.6%
JEFFERSON COUNTY HOSPITALOK25$41.1M14.4%
PHYSICIANS HOSPITAL AT ANADARKOK25$34.1M-48.1%
LAKESIDE WOMENS HOSPITALOK23$33.0M16.5%
STROUD REGIONAL MEDICAL CENTEROK25$31.4M-50.0%
SURGICAL HOSPITAL OF OKLAHOMAOK12$31.2M-13.0%
HILLCREST HOSPITAL PRYOROK21$30.6M-7.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $319K (767bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$88K+212bp12mo
Net Collection Rate93.5%97.0%$87K+210bp18mo
Cost to Collect4.5%2.5%$83K+200bp12mo
A/R Days Reduction5200.0%3800.0%$51K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+23bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$88K
Net Collection Rate
$87K
Cost to Collect
$83K
A/R Days Reduction
$51K
Clean Claim Rate
$10K
Total EBITDA Uplift$319K
Current EBITDA$-15.5M
+ RCM Uplift+$319K
Pro Forma EBITDA$-15.2M
Current Margin-100.0%
Pro Forma Margin-365.6%
WC Released (1x)$159K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-23.9M$-99.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-23.9M$-116.8M0.00x-100.0%
Bull Case9.0x11.0x$-21.5M$-123.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-21.5M$-141.1M0.00x-100.0%
Bear Case11.0x10.0x$-26.3M$-93.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-26.3M$-110.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (55.5%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 51.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 8-32 beds
  • Same-state prioritization (n=61)
  • Comp margins: P25=-28.2% / P50=-17.8% / P75=-5.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.